Question 1

Does Morgan Stanley own GLPG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Morgan Stanley holds 37,682 shares of GLPG (Lakefront Biotherapeutics), worth $1.1M.

Question 2

How many shares of GLPG does Morgan Stanley own?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley holds 37,682 shares of GLPG (Lakefront Biotherapeutics).

Question 3

What is Morgan Stanley's GLPG position worth?

Accepted Answer

As of its Q2 2026 13F, Morgan Stanley's GLPG position is worth $1.1M.

Question 4

Is Morgan Stanley buying or selling GLPG?

Accepted Answer

In Q2 2026, Morgan Stanley increased its GLPG position by 11,063 shares (+41.6%).

Question 5

When did Morgan Stanley first buy GLPG?

Accepted Answer

Morgan Stanley already held GLPG in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	37,682	+41.6%	$1.1M	0.0%	$27.73	34
2026-Q1	Decreased	26,619	-61.0%	$798,570	0.0%	$33.05	0
2025-Q4	Increased	68,285	+6.6%	$2.2M	0.0%	$32.61	28
2025-Q3	Decreased	64,063	-3.2%	$2.2M	0.0%	$34.43	0
2025-Q2	Increased	66,164	+160.4%	$1.9M	0.0%	$27.98	42
2025-Q1	Decreased	25,407	-82.4%	$638,224	0.0%	$25.46	0
2024-Q4	Increased	144,137	+70.9%	$4M	0.0%	$27.30	40
2024-Q3	Decreased	84,355	-25.8%	$2.4M	0.0%	$29.28	0
2024-Q2	First report	113,729	-	$2.8M	0.0%	$24.78	0

GLPG9 quarters

GLPG
9 quarters